Literature DB >> 20978771

Functional role of TASK-1 in the heart: studies in TASK-1-deficient mice show prolonged cardiac repolarization and reduced heart rate variability.

Birgit C Donner1, Martina Schullenberg, Nora Geduldig, Anja Hüning, Jan Mersmann, Kai Zacharowski, Alexander Kovacevic, Ulrich Decking, Maria Isabel Aller, Klaus G Schmidt.   

Abstract

TASK-1, a member of the recently identified K2P channel family, is mainly expressed in the heart and the nervous system. TASK-1 is regulated by several physiological and pathological conditions and functions as a background potassium channel. However, there are limited data concerning the significance of TASK-1 in cardiac physiology. We studied the functional role of TASK-1 in the heart by cardiac phenotyping the TASK-1-deficient mouse (TASK-1(-/-)). TASK-1 was predominantly expressed in the ventricles of control animals. Real-time PCR and immunoblot demonstrated that the expression of seven other K2P channels was unchanged in TASK-1(-/-) mice. No structural or functional abnormalities were found by histology and echocardiography. Electrophysiological studies recording monophasic action potentials (MAPs) showed a significant prolongation of action potential duration in spontaneously beating and atrially paced hearts, respectively. Surface ECGs of TASK-1(-/-) mice revealed a significant prolongation of the rate corrected QT interval. Telemetric ECG recordings for 24 h, during physical and pharmacological stress testing and after ischemia/reperfusion injury did not result in a higher incidence of arrhythmias. Infarct size was comparable in both genotypes. However, TASK-1(-/-) mice had a higher mean heart rate and significantly reduced heart rate variability (HRV). Time and frequency domain measurements as well as baroreceptor reflex testing revealed a sympathovagal imbalance with a shift to an increase in sympathetic influence in TASK-1(-/-) mice. In conclusion, TASK-1 plays a functional role in the repolarization of the cardiac action potential in vivo and contributes to the maintenance of HRV.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20978771     DOI: 10.1007/s00395-010-0128-x

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  29 in total

1.  Breathing Stimulant Compounds Inhibit TASK-3 Potassium Channel Function Likely by Binding at a Common Site in the Channel Pore.

Authors:  Rikki H Chokshi; Aaron T Larsen; Brijesh Bhayana; Joseph F Cotten
Journal:  Mol Pharmacol       Date:  2015-08-12       Impact factor: 4.436

Review 2.  The family of K2P channels: salient structural and functional properties.

Authors:  Sylvain Feliciangeli; Frank C Chatelain; Delphine Bichet; Florian Lesage
Journal:  J Physiol       Date:  2015-01-22       Impact factor: 5.182

Review 3.  Much more than a leak: structure and function of K₂p-channels.

Authors:  Vijay Renigunta; Günter Schlichthörl; Jürgen Daut
Journal:  Pflugers Arch       Date:  2015-03-21       Impact factor: 3.657

4.  A lower X-gate in TASK channels traps inhibitors within the vestibule.

Authors:  Karin E J Rödström; Aytuğ K Kiper; Wei Zhang; Susanne Rinné; Ashley C W Pike; Matthias Goldstein; Linus J Conrad; Martina Delbeck; Michael G Hahn; Heinrich Meier; Magdalena Platzk; Andrew Quigley; David Speedman; Leela Shrestha; Shubhashish M M Mukhopadhyay; Nicola A Burgess-Brown; Stephen J Tucker; Thomas Müller; Niels Decher; Elisabeth P Carpenter
Journal:  Nature       Date:  2020-04-29       Impact factor: 49.962

Review 5.  The role of acid-sensitive two-pore domain potassium channels in cardiac electrophysiology: focus on arrhythmias.

Authors:  Niels Decher; Aytug K Kiper; Caroline Rolfes; Eric Schulze-Bahr; Susanne Rinné
Journal:  Pflugers Arch       Date:  2014-11-19       Impact factor: 3.657

6.  Physiological genomics identifies genetic modifiers of long QT syndrome type 2 severity.

Authors:  Sam Chai; Xiaoping Wan; Angelina Ramirez-Navarro; Paul J Tesar; Elizabeth S Kaufman; Eckhard Ficker; Alfred L George; Isabelle Deschênes
Journal:  J Clin Invest       Date:  2018-02-12       Impact factor: 14.808

7.  pH-dependent inhibition of K₂P3.1 prolongs atrial refractoriness in whole hearts.

Authors:  Mark A Skarsfeldt; Thomas A Jepps; Sofia H Bomholtz; Lea Abildgaard; Ulrik S Sørensen; Emilie Gregers; Jesper H Svendsen; Jonas G Diness; Morten Grunnet; Nicole Schmitt; Søren-Peter Olesen; Bo H Bentzen
Journal:  Pflugers Arch       Date:  2016-01-05       Impact factor: 3.657

8.  Carvedilol targets human K2P 3.1 (TASK1) K+ leak channels.

Authors:  K Staudacher; I Staudacher; E Ficker; C Seyler; J Gierten; J Kisselbach; A-K Rahm; K Trappe; P A Schweizer; R Becker; H A Katus; D Thomas
Journal:  Br J Pharmacol       Date:  2011-07       Impact factor: 8.739

9.  TASK-1 current is inhibited by phosphorylation during human and canine chronic atrial fibrillation.

Authors:  Erin Harleton; Alessandra Besana; Parag Chandra; Peter Danilo; Tove S Rosen; Michael R Rosen; Michael Argenziano; Richard B Robinson; Steven J Feinmark
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-11-26       Impact factor: 4.733

10.  Ability to induce atrial fibrillation in the peri-operative period is associated with phosphorylation-dependent inhibition of TWIK protein-related acid-sensitive potassium channel 1 (TASK-1).

Authors:  Erin Harleton; Alessandra Besana; George M Comas; Peter Danilo; Tove S Rosen; Michael Argenziano; Michael R Rosen; Richard B Robinson; Steven J Feinmark
Journal:  J Biol Chem       Date:  2012-12-10       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.